ArticleCancer medicine2021

First-line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study.

Shigeo Shimose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.